iShares Biotechnology ETF (NASDAQ:IBB) Stock Position Lowered by Boston Research & Management Inc.

Boston Research & Management Inc. trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 3.7% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,242 shares of the financial services provider’s stock after selling 545 shares during the quarter. Boston Research & Management Inc.’s holdings in iShares Biotechnology ETF were worth $1,954,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently added to or reduced their stakes in the company. AE Wealth Management LLC increased its stake in shares of iShares Biotechnology ETF by 10.7% during the 2nd quarter. AE Wealth Management LLC now owns 2,034 shares of the financial services provider’s stock worth $279,000 after purchasing an additional 196 shares during the last quarter. Waters Parkerson & CO. LLC increased its position in iShares Biotechnology ETF by 54.2% during the second quarter. Waters Parkerson & CO. LLC now owns 3,700 shares of the financial services provider’s stock worth $508,000 after buying an additional 1,300 shares during the last quarter. Hsbc Holdings PLC raised its holdings in iShares Biotechnology ETF by 47.1% during the second quarter. Hsbc Holdings PLC now owns 3,670 shares of the financial services provider’s stock valued at $504,000 after buying an additional 1,175 shares in the last quarter. Bradley Foster & Sargent Inc. CT raised its holdings in iShares Biotechnology ETF by 4.8% during the second quarter. Bradley Foster & Sargent Inc. CT now owns 10,792 shares of the financial services provider’s stock valued at $1,481,000 after buying an additional 492 shares in the last quarter. Finally, Perennial Investment Advisors LLC acquired a new stake in shares of iShares Biotechnology ETF in the second quarter worth about $216,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 1.0 %

IBB opened at $147.98 on Friday. The stock has a 50-day moving average of $145.80 and a 200-day moving average of $138.61. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $150.57.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.